City of Colleyville Defective Breast Mesh & Implant Injury Attorneys: Attorney911 brings Ralph Manginello’s 27+ Years of Federal Trial Experience to North Texas — We Litigate Allergan BIOCELL Textured Implants (Recalled July 2019, MDL 2921 Before Judge Martinotti, Bellwether October 19, 2026), Mentor MemoryGel, Sientra OPUS, AlloDerm ADM, and GalaFLEX P4HB Bioabsorbable Scaffolds, CD30+/ALK- BIA-ALCL and BIA-SCC Pathology Authority, Federal Preemption under Riegel v. Medtronic and Lohr, 21 CFR Parts 803, 807 and 814 — Lupe Peña Former Insurance Defense Counsel leads Consultations in Fluent Spanish, Texas 2-Year Statute of Limitations (CPRC § 16.003) with Discovery Rule Analysis, $50M+ Recovered and Active $10M Bermudez Litigation, Free 24/7 Consultation, No Fee Unless We Recover Compensation for You, Hablamos Español, 1-888-ATTY-911
Defective Breast Mesh, Acellular Dermal Matrix (ADM), and Bioabsorbable Scaffold Injury Attorneys in City of Colleyville: The Definitive Guide for Women, Families, and Survivors For women in City of Colleyville who have undergone breast reconstruction, revision, or cosmetic augmentation, the expectation is always one of healing and restoration. Whether you are a breast cancer survivor recovering at localized Tarrant County centers or a patient who sought aesthetic improvement in the Dallas-Fort Worth metroplex, the materials placed inside your body were supposed to be safe. We know that for many our neighbors in City of Colleyville, that promise has been broken. At The Manginello Law Firm, PLLC (Attorney911), we see the reality behind the clinical terminology of "surgical mesh," "acellular dermal matrix," and "bioabsorbable scaffolds." We recognize that for our clients in City of Colleyville, these are not just medical devices; they are products that may have caused life-altering infections, permanent disfigurement, and even rare forms of cancer like BIA-ALCL and BIA-SCC. Ralph Manginello and our entire legal team are dedicated to helping women in City of Colleyville understand why these devices failed and how the federal regulatory shortcuts used by manufacturers like Becton Dickinson (BD), Allergan, and Integra LifeSciences have…